Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention

Circ Cardiovasc Interv. 2021 Jul;14(7):e010565. doi: 10.1161/CIRCINTERVENTIONS.121.010565. Epub 2021 Jun 16.

Abstract

[Figure: see text].

Trial registration: ClinicalTrials.gov NCT01944800.

Keywords: acute coronary syndrome; myocardial infarction; percutaneous coronary intervention; stroke; ticagrelor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors / adverse effects
  • Prasugrel Hydrochloride / adverse effects
  • Ticagrelor / adverse effects
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride
  • Ticagrelor

Associated data

  • ClinicalTrials.gov/NCT01944800